These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36636410)

  • 1. Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study.
    Taniguchi Y; Matsuda Y; Mori M; Ito M; Ikari T; Tokoro A; Aiki S; Hoshino S; Kiuchi D; Suzuki K; Igarashi Y; Odagiri T; Oya K; Kubo E; Yamaguchi T
    Transl Lung Cancer Res; 2022 Dec; 11(12):2395-2402. PubMed ID: 36636410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study.
    Yamaguchi T; Matsunuma R; Matsuda Y; Tasaki J; Ikari T; Miwa S; Aiki S; Takagi Y; Kiuchi D; Suzuki K; Oyamada S; Ariyoshi K; Kihara K; Mori M
    J Pain Symptom Manage; 2023 May; 65(5):400-408. PubMed ID: 36641006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Successful Is Parenteral Oxycodone for Relieving Terminal Cancer Dyspnea Compared With Morphine? A Multicenter Prospective Observational Study.
    Mori M; Kawaguchi T; Imai K; Yokomichi N; Yamaguchi T; Suzuki K; Matsunuma R; Watanabe H; Maeda I; Uehara Y; Morita T;
    J Pain Symptom Manage; 2021 Aug; 62(2):336-345. PubMed ID: 33290857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study.
    Mori M; Kawaguchi T; Imai K; Yokomichi N; Yamaguchi T; Suzuki K; Matsunuma R; Watanabe H; Maeda I; Matsumoto Y; Matsuda Y; Morita T;
    J Pain Symptom Manage; 2021 Nov; 62(5):936-948. PubMed ID: 33992759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study.
    Mori M; Morita T; Matsuda Y; Yamada H; Kaneishi K; Matsumoto Y; Matsuo N; Odagiri T; Aruga E; Watanabe H; Tatara R; Sakurai H; Kimura A; Katayama H; Suga A; Nishi T; Shirado AN; Watanabe T; Kuchiba A; Yamaguchi T; Iwase S
    Support Care Cancer; 2020 Jul; 28(7):3051-3060. PubMed ID: 31630256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07.
    Matsuda Y; Morita T; Matsumoto H; Hosoi K; Kusama K; Kohashi Y; Morishita H; Kaku S; Ariyoshi K; Oyamada S; Inoue Y; Iwase S; Yamaguchi T; Nishikawa M
    Palliat Med Rep; 2021; 2(1):15-20. PubMed ID: 34223498
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of opioid switching for dyspnea and its predictors in cancer patients: a single-center retrospective observational study.
    Yamamoto Y; Tanaka S; Matsuura K; Yamamoto S; Urano K; Okita J; Kato E; Odagiri T; Deguchi Y
    Jpn J Clin Oncol; 2024 May; 54(5):549-555. PubMed ID: 38323655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
    Maeda T; Hayakawa T
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study.
    Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
    J Palliat Med; 2017 Apr; 20(4):352-359. PubMed ID: 28379811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H; McDonald J; Smallwood N; Manser R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.
    Strieder M; Pecherstorfer M; Kreye G
    Wien Med Wochenschr; 2018 Oct; 168(13-14):333-343. PubMed ID: 28921042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study.
    Mori M; Shirado AN; Morita T; Okamoto K; Matsuda Y; Matsumoto Y; Yamada H; Sakurai H; Aruga E; Kaneishi K; Watanabe H; Yamaguchi T; Odagiri T; Hiramoto S; Kohara H; Matsuo N; Katayama H; Nishi T; Matsui T; Iwase S
    Support Care Cancer; 2017 Apr; 25(4):1169-1181. PubMed ID: 27900548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
    Luo N; Tan S; Li X; Singh S; Liu S; Chen C; Huang Z; Feng S; Lin Y; Lin Y; Cen H; Liang M; Chen M
    J Pain Symptom Manage; 2021 Jan; 61(1):198-210.e1. PubMed ID: 32730950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer.
    Gemma A; Kudoh S; Ando M; Ohe Y; Nakagawa K; Johkoh T; Yamazaki N; Arakawa H; Inoue Y; Ebina M; Kusumoto M; Kuwano K; Sakai F; Taniguchi H; Fukuda Y; Seki A; Ishii T; Fukuoka M
    Cancer Sci; 2014 Dec; 105(12):1584-90. PubMed ID: 25287435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study.
    Mori M; Yamaguchi T; Suzuki K; Matsuda Y; Matsunuma R; Watanabe H; Ikari T; Matsumoto Y; Imai K; Yokomichi N; Miwa S; Yamauchi T; Okamoto S; Inoue S; Inoue A; Morita T; Satomi E;
    Cancer Med; 2023 Mar; 12(5):5397-5408. PubMed ID: 36259645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine for Refractory Dyspnea in Interstitial Lung Disease: A Phase I Study (JORTC-PAL 05).
    Matsuda Y; Morita T; Miyaji T; Ogawa T; Kato K; Kawaguchi T; Tokoro A; Iwase S; Yamaguchi T; Inoue Y
    J Palliat Med; 2018 Dec; 21(12):1718-1723. PubMed ID: 30129820
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
    van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
    BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias.
    Matsuda Y; Maeda I; Tachibana K; Nakao K; Sasaki Y; Sugimoto C; Arai T; Tokoro A; Akira M; Inoue Y
    J Palliat Med; 2017 Aug; 20(8):879-883. PubMed ID: 28437202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians.
    Matsuda Y; Matsunuma R; Suzuki K; Mori M; Watanabe H; Yamaguchi T
    Palliat Med Rep; 2020; 1(1):97-102. PubMed ID: 34223464
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.